A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Genmab A/S stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 1,400 shares of GMAB stock, worth $28,826. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,400
Previous 1,400 -0.0%
Holding current value
$28,826
Previous $35,000 2.86%
% of portfolio
0.02%
Previous 0.02%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$27.94 - $35.44 $19,558 - $24,808
-700 Reduced 33.33%
1,400 $44,000
Q3 2021

Nov 10, 2021

BUY
$41.55 - $48.72 $12,465 - $14,616
300 Added 16.67%
2,100 $92,000
Q2 2021

Aug 12, 2021

SELL
$32.88 - $44.57 $16,440 - $22,285
-500 Reduced 21.74%
1,800 $73,000
Q1 2021

May 11, 2021

SELL
$30.92 - $44.4 $21,644 - $31,080
-700 Reduced 23.33%
2,300 $76,000
Q4 2020

Feb 11, 2021

SELL
$33.66 - $40.76 $13,463 - $16,304
-400 Reduced 11.76%
3,000 $122,000
Q3 2020

Nov 12, 2020

BUY
$33.07 - $38.68 $6,614 - $7,736
200 Added 6.25%
3,400 $124,000
Q2 2020

Aug 10, 2020

BUY
$20.05 - $33.89 $64,160 - $108,448
3,200 New
3,200 $108,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Mark Sheptoff Financial Planning, LLC Portfolio

Follow Mark Sheptoff Financial Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.